Matinas BioPharma Holdings (MTNB) Total Non-Current Liabilities (2014 - 2026)
Matinas BioPharma Holdings (MTNB) recorded Total Non-Current Liabilities of $262,000 in Q2 2026, down 86.7% from $1.97 million a year earlier and down 63.9% from the prior quarter.
Powered by 
Analysis
Matinas BioPharma Holdings (MTNB) Total Non-Current Liabilities (2014 - 2026) Analysis & Trends
At the end of FY2025, Matinas BioPharma Holdings reported Total Non-Current Liabilities of $915,000, down 61.6% from FY2024.
- Annual Total Non-Current Liabilities has declined for four straight years, with a five-year compound annual growth rate of -24.3% (FY2020 to FY2025).
- Across earlier years, Total Non-Current Liabilities came in at $2.39 million in FY2024 (-26.3%), $3.24 million in FY2023 (-16.9%), $3.9 million in FY2022 (-13.1%) and $4.48 million in FY2021 (+22.2%).
- The Q2 2026 figure is the lowest quarterly Total Non-Current Liabilities in data going back to Q4 2014.
- On a year-over-year basis, Total Non-Current Liabilities has declined for five consecutive quarters, with an average decline of 40.9% over the last eight quarters.
- Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 23.1% in Q3 2021, against a decline of 86.7% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $726,000 (Q1 2026), $915,000 (Q4 2025) and $1.74 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,209.53 Bn | 1,178.12 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 625.18 Bn | 543.70 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 510.63 Bn | 483.79 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 365.88 Bn | 320.31 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 293.11 Bn | 257.51 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.69 Bn | 235.45 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 237.29 Bn | 192.69 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 194.23 Bn | 168.34 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 171.73 Bn | 118.68 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Matinas BioPharma Holdings | 696,138.77 | -11.90 Mn | - | 262,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 262,000.00 |
| Mar 31, 2026 | 726,000.00 |
| Dec 31, 2025 | 915,000.00 |
| Sep 30, 2025 | 1.74 Mn |
| Jun 30, 2025 | 1.97 Mn |
| Mar 31, 2025 | 3.51 Mn |
| Dec 31, 2024 | 2.39 Mn |
| Sep 30, 2024 | 2.67 Mn |
| Jun 30, 2024 | 2.87 Mn |
| Mar 31, 2024 | 3.05 Mn |
| Dec 31, 2023 | 3.24 Mn |
| Sep 30, 2023 | 3.41 Mn |
| Jun 30, 2023 | 3.58 Mn |
| Mar 31, 2023 | 3.74 Mn |
| Dec 31, 2022 | 3.90 Mn |
| Sep 30, 2022 | 4.03 Mn |
| Jun 30, 2022 | 4.18 Mn |
| Mar 31, 2022 | 4.33 Mn |
| Dec 31, 2021 | 4.48 Mn |
| Sep 30, 2021 | 4.63 Mn |
API Access
Matinas BioPharma Holdings Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=MTNB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "MTNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=MTNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();